Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $50.0000 (-2.31%) ($49.9500 - $50.0000) on Fri. Apr. 30, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.81% (three month average) | RSI | 86 | Latest Price | $50.0000(-2.31%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.3% a day on average for past five trading days. | Weekly Trend | HALO advances 6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(50%) IWO(49%) IWM(47%) IWC(44%) IWN(43%) | Factors Impacting HALO price | HALO will decline at least -1.405% in a week (0% probabilities). VIXM(-31%) VXX(-12%) UUP(-11%) IGOV(-3%) GLD(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.405% (StdDev 2.81%) | Hourly BBV | -1.8 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $50.75(-1.48%) | 10 Day Moving Average | $49.76(0.48%) | 20 Day Moving Average | $46.93(6.54%) | To recent high | -3.8% | To recent low | 26.3% | Market Cap | $6.834b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |